The gene mutated in Nijmegen breakage syndrome, a chromosome instability disorder, has been identified and sequenced. The protein product of this gene forms a complex with hMre11 and hRad50 -proteins that are involved in repairing double-strand breaks in DNA.
The similarities in the characteristics of cells from NBS and AT patients nonetheless suggest that the defective functions in both diseases might be related. In particular, both NBS and AT cells display chromosomal instability, most notably of chromosomes 7 and 14 [2, 3] where the genes for immunoglobulins and T-cell receptors are located. Also, in both conditions the cells are hypersensitive to ionizing radiation, their chromosomes have high levels of radiation-induced chromosome fragility, and DNA replication is not delayed in response to ionizing radiation like it is in normal cells [2] . This cell-cycle checkpoint defect may be due, in part, to a delayed and reduced induction of the checkpoint tumour suppressor protein p53 in response to irradiation [4, 5] .
The defective gene in AT, ATM, maps to chromosome 11q23 and encodes a member of the phosphatidylinositol-3 kinase family that is related to the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) -a protein involved in DNA double-strand-break repair and in recombination of the V(D)J regions of immunoglobulin and T-cell receptor genes, which generates antibody and antigen receptor diversity [6] . The product of the ATM gene appears to be involved in signalling DNA damage to p53 [6] . Mapping of the gene affected in NBS -termed NBS1 -to a 1 centimorgan region on chromosome 8q21 [7] and, by a method of chromosome transfer involving cell fusion, to chromosome 8q21-24 [8] strongly suggested that NBS1 was distinct from ATM.
This conclusion is now unequivocal since the chromosomal mapping location of the NBS1 gene was confirmed recently by positional cloning [9, 10] . Nevertheless, the phenotypic similarities between the two diseases, and the lack of complementation for radiation-induced chromosomal aberrations in NBS-AT cell fusions [11] , suggest that the two gene products may work closely in the same biochemical pathway, and perhaps even in the same protein complex [11] . In an unrelated study, Petrini and colleagues [12] identified the protein encoded by the NBS1 gene as a component of a complex that is implicated in repairing the DNA double-strand breaks that are induced by DNA-damaging agents and that occur naturally during meiotic recombination. These findings provide a framework within which the molecular basis of NBS might be explained as a defect in signalling and/or repairing DNA double-strand breaks.
The NBS1 protein
The NBS1 gene encodes a polypeptide of 754 amino acids with a predicted molecular mass of 85 kDa that Varon et al. [9] named nibrin, and Petrini and colleagues [12] call NBS1. Most cases of NBS are due to a common founder mutation in NBS1. The mutation, 657del5, is a 5 base pair deletion that results in premature truncation of the protein product 15 amino acids downstream of the deletion site [9, 10] . Overall, NBS1 has no striking primary sequence similarity to previously characterized proteins. It has two recognizable domains, however, within the amino-terminal 200 amino acids: one forkhead-associated (FHA) domain and one breast cancer carboxy-terminal (BRCT) domain (Figure 1 ). Both types of domain have been found individually in a variety of proteins but they have never before been found adjacent to each other within the same protein.
The BRCT domain was first identified in the carboxyl terminus of the breast cancer susceptibility protein BRCA1 [13] and, to date, has been found in over 40 other proteins that function predominantly in DNA repair and DNA damage checkpoints [14] . On structural grounds, the BRCT domain is expected to be involved in protein-protein interactions, and this seems to be the case for the domains in DNA ligase III [15] and poly(ADP-ribose) polymerase [16] that bind to XRCC1, and the domain in DNA ligase IV that binds to XRCC4 [17] .
The FHA domain was originally identified in a subset of the forkhead family of transcription factors, and has subsequently been found in around 20 unrelated proteins [18] . Like NBS1, all but one of the characterized FHA-containing proteins are nuclear, and most of the uncharacterized proteins contain putative bipartite nuclear localization signals. Four of the FHA-domain-containing proteins are yeast protein kinases that are involved in meiotic recombination and respond to signals related to DNA replication and repair. As yet, there is no known function for FHA domains. There is a hint, however, that the domains might mediate interactions with phosphoproteins: the FHAdomain-containing kinase-associated protein phosphatase (KAPP) from Arabidopsis thaliana interacts with its target kinase only when the kinase is autophosphorylated on serine and threonine residues, and the site of this interaction maps to the region in KAPP that contains the FHA domain [19] . By analogy, NBS1 might therefore interact with a phosphoprotein in the DNA repair apparatus.
The function of NBS1
NBS1 was found to have a role in DNA repair virtually at the same time as the cloning of the NBS1 gene when Carney et al. [12] discovered that the gene encoding p95, a component of the human Mre11-Rad50-containing DNA repair complex, was identical to NBS1. The MRE11 and RAD50 genes were originally identified from mutations in the budding yeast Saccharomyces cerevisiae that cause hypersensitivity to ionizing radiation and an inability to initiate and/or complete meiosis [20] . Both gene products are involved in repairing DNA double-strand breaks formed by ionizing radiation, and in the initiation and processing of DNA double-strand breaks in meiotic recombination [21] . Rad50p and Mre11p appear to be homologues of the Escherichia coli proteins SbcC and SbcD, respectively [22] , which together have DNA exonuclease and endonuclease activity [23] , suggesting that Mre11p and Rad50p might also have these activities.
Carney et al. [12] isolated a complex from human cells that contained hMre11, hRad50 and several other polypeptides. They obtained sequence information for a copurifying polypeptide of 95 kDa -p95 -and used it to construct a cDNA from overlapping expressed sequence tags in the human genome database and to predict the amino acid sequence of p95. The gene encoding p95 was localized to chromosome 8q21.3 indicating that it was probably the gene defective in NBS patients that had been mapped to this location the previous year. The recent sequencing of the NBS1 gene [9, 10] verified that NBS1 was identical to the gene encoding p95 [12] . Further confirmation was provided by the finding that the p95 protein and its mRNA are absent from NBS cells [12] .
Carney and colleagues found that NBS1 binds to hMre11 in a yeast two-hybrid protein-protein interaction screen. Together with hMre11, hRad50 and possibly other polypeptides, NBS1 forms a complex with an estimated molecular mass of 1600 kDa [12] . NBS1 is not required for the interaction between hMre11 and hRad50, but it does seem to be required for the subcellular relocation of these proteins in response to DNA damage. Before treatment of cells with ionizing radiation, both hMre11 and hRad50 are distributed diffusely throughout the nucleoplasm, presumably in a complex. After irradiation, however, hMre11 Dispatch R623
Figure 1
The domain structure of NBS1 is shown diagrammatically. It comprises adjacent FHA and BRCT domains spanning the aminoterminal 200 amino acids of the polypeptide and a 550 amino acid tail with no apparent homology to other proteins. In general, FHA domains are 55-75 amino acids in size with indistinct boundaries. They contain three highly conserved blocks (blue) that are predicted to form β strands, separated by more divergent spacer sequences. The only invariant residues are a glycine-arginine pair (GR) in the first block and a histidine (H) in the second. The FHA domain is distinct from the forkhead domain (FD) that is also found in the forkhead family of transcription factors. BRCT domains are about 95 residues long and comprise five highly conserved blocks (yellow) designated A-E. The only invariant residue is a tryptophan (W) in block D. The two residues at the end of block B are frequently G or A. The domain is predicted to contain four β strands, probably forming a core sheet structure, and two α helices. The arrow indicates the location of the common founder mutation in NBS patients (657del5). and hRad50 are found in foci within the nucleus [24] . These foci may be individual sites of double-strand breaks in the DNA or they may correspond to subnuclear structures that somehow organize the DNA repair machinery. By contrast, these foci of hMre11 and hRad50 do not appear in response to ionizing radiation in cells that lack NBS1. Formation of the foci is also drastically reduced in AT cells [24] , suggesting that ATM might recruit the hMre11-hRad50 complex to the double-strand break or trigger signalling pathways that result in the relocation of the complex.
In S. cerevisiae, Mre11p and Rad50p form a complex with at least one other protein (of approximately 95 kDa), Xrs2p, which is also involved in repairing double-strand DNA breaks [20] . In the human complex, the p95 protein -which is now known to be NBS1 -was interesting at first because of its similarity in size to Xrs2p, indicating that it might be the human homologue of this protein. Surprisingly, the sequences of the two proteins are relatively dissimilar, having a sequence identity of 28% only over their first 115 amino acid residues. No other protein encoded in the yeast genome appears to be a closer relative of NBS1, however, so NBS1 might be a functional analogue or a distantly related homologue of Xrs2p.
A model for the function of the NBS1-Mre11-Rad50 complex
How then might NBS1 function? From its association with hMre11 and hRad50, and its similarity with Xrs2p, it seems likely that NBS1 will function in the recognition, repair and/or signalling of DNA double-strand breaks.
Breaks that form in response to DNA-damaging agents, such as ionizing radiation, might be recognized directly by NBS1 or, more likely, NBS1 might recognize a signal from a DNA-break-detecting complex, which may contain DNA-PK and/or ATM (Figure 2 ). By analogy with the Arabidopsis protein KAPP, this signal might be phosphorylation on a serine or threonine residue in a target protein that would then be recognized by the FHA domain in NBS1. Alternatively, other protein-protein interactions might be involved, for example through the BRCT domain in NBS1. In binding to a component at the double-strand break, NBS1 might act as an adaptor bringing the Mre11-Rad50 exonuclease activity to the DNA ends to prepare them for ligation. In doing so, it may also recruit other components in the complex to facilitate the repair process. Because NBS cells are defective in the control of cell-cycle checkpoints [4, 5] , NBS1 itself, or the consequences of its action, must also impinge on the DNA-damage signalling pathways to induce a delay in DNA replication.
Towards a molecular explanation of NBS
This new knowledge of the NBS1 gene and the role of its product in the complex containing hMre11 and hRad50 suggest how the cellular phenotypes of NBS cells might arise. Certain features of NBS, including chromosomal instability, sensitivity to DNA-damaging agents and failure to induce checkpoint controls, might be explained by the absence of a protein that is crucial for recognizing, signalling and repairing DNA double-strand breaks. The clinical symptoms of immunodeficiency might be explained if there are defects in the essential gene rearrangements that A model for the function of the NBS1 protein. NBS1 is part of a ~1600 kDa complex that contains hMre11, hRad50 and, most likely, other proteins. When double-strand breaks occur in the DNA, for example upon treatment with ionizing radiation or with radiomimetic drugs such as bleomycin, they are most probably recognized by a complex of proteins that may include, or interact with, ATM or DNA-PK. One of these kinases may then phosphorylate a substrate in the complex that provides a recognition site for the NBS1-hMre11-hRad50 complex, and/or some other type of protein-protein interaction may occur, causing the relocalization of the complex from diffuse points in the nucleus to foci of DNA repair. The recruited NBS1-hMre11-hRad50 complex may then promote repair, for example by exonuclease action on the DNA ends, and may also signal to the cell-cycle checkpoint machinery, for example to prevent p53 turnover thereby increasing the cellular levels of p53. generate the immunoglobulin and T-cell receptor repertoire or that are involved in the switching of immunoglobulin isotypes. The predisposition to malignancy, especially in lymphoid cells, might be explained by the accumulation of unrepaired chromosomal damage, leading to the deletions and translocations typical of tumorigenesis. Finally, the frequent occurrence and compromised repair of chromosomal damage might make the cells of NBS patients grow more slowly, or cause them to undergo apoptosis more frequently, possibly producing the developmental defects typical of NBS -microcephaly and growth retardation. Given that Mre11 is essential for mouse embryonic stem cell viability [25] , it will be interesting to know whether the NBS1-Mre11-Rad50 complex also performs other roles in embryonic and foetal development.
